Literature DB >> 15452805

Results of extracapsular dissection of pleomorphic adenoma of parotid gland.

Janusz Piekarski1, Dariusz Nejc, Wieslaw Szymczak, Konrad Wronski, Arkadiusz Jeziorski.   

Abstract

PURPOSE: Current opinion that extracapsular dissection is in fact a euphemism for enucleation prompted us to retrospectively identify all patients in whom the extracapsular dissection technique was used and to critically assess the value of this technique. PATIENTS AND METHODS: The study includes all patients who underwent extracapsular dissection of parotid pleomorphic adenoma from 1979 to 2002 in our department (Department of Surgical Oncology, Medical University of Lodz, Poland). Ninety-eight cases were evaluated. Mean tumor diameter was 3.6 cm (range, 1.5 to 10 cm; median, 3 cm).
RESULTS: In 8 cases (8/98; 8.2%) local recurrence was observed. For the entire group, the probability of living 10 years without the recurrence of the disease was 0.58. The lowest probability of local recurrence was found in patients with tumors larger than 4 to 6 cm in diameter. In these cases, the extensiveness of resection was similar to superficial parotidectomy, which could explain the result. In 13 cases (13/98; 13.3%) capsular exposure was found and consequently microscopic disease was present at the excision margins. In 7 cases (7/98; 7.1%) capsular rupture took place during surgery. The persistent paresis of facial nerve was observed in 8 cases (8/98; 8.2%).
CONCLUSION: Extracapsular dissection of pleomorphic adenoma is a very demanding technique. Inevitable eventual clinical errors (eg, incomplete resection) lead to unacceptably high incidences of recurrences and complications. We do not advise this technique for the treatment of pleomorphic adenoma.

Entities:  

Mesh:

Year:  2004        PMID: 15452805     DOI: 10.1016/j.joms.2004.01.025

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  12 in total

Review 1.  Surgical options in benign parotid tumors: a proposal for classification.

Authors:  Miquel Quer; Vincent Vander Poorten; Robert P Takes; Carl E Silver; Carsten C Boedeker; Remco de Bree; Alessandra Rinaldo; Alvaro Sanabria; Ashok R Shaha; Albert Pujol; Peter Zbären; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-21       Impact factor: 2.503

Review 2.  Treatment of complications of parotid gland surgery.

Authors:  R Marchese-Ragona; C De Filippis; G Marioni; A Staffieri
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-06       Impact factor: 2.124

Review 3.  [Diagnostic and therapy of salivary gland diseases: relevant aspects for the pathologist from the clinical perspective].

Authors:  C Wittekindt; H P Burmeister; O Guntinas-Lichius
Journal:  Pathologe       Date:  2009-11       Impact factor: 1.011

Review 4.  Parotid surgery for benign tumours.

Authors:  Farzad Borumandi; Katherine S George; Luke Cascarini
Journal:  Oral Maxillofac Surg       Date:  2012-07-31

5.  Which Surgical Method is Superior for the Treatment of Parotid Tumor? Is it Classical? Is it New?

Authors:  Vahit Mutlu; Zulkuf Kaya
Journal:  Eurasian J Med       Date:  2019-10

6.  Pleomorphic adenoma of the parotid: extracapsular dissection compared with superficial parotidectomy--a 10-year retrospective cohort study.

Authors:  Maria Giulia Cristofaro; Eugenia Allegra; Amerigo Giudice; Walter Colangeli; Davide Caruso; Ida Barca; Mario Giudice
Journal:  ScientificWorldJournal       Date:  2014-10-21

Review 7.  Why Do Parotid Pleomorphic Adenomas Recur? A Systematic Review of Pathological and Surgical Variables.

Authors:  Pavel Dulguerov; Jelena Todic; Marc Pusztaszeri; Naif H Alotaibi
Journal:  Front Surg       Date:  2017-05-15

8.  Massive transcranial parotid pleomorphic adenoma: recurrence after 30 years.

Authors:  Graham M Strub; Alexandros Georgolios; Robert S Graham; Celeste N Powers; Daniel H Coelho
Journal:  J Neurol Surg Rep       Date:  2012-10

Review 9.  PRISMA-Extracapsular Dissection Versus Superficial Parotidectomy in Treatment of Benign Parotid Tumors: Evidence From 3194 Patients.

Authors:  Shang Xie; Kan Wang; Hui Xu; Rui-Xi Hua; Tian-Zhu Li; Xiao-Feng Shan; Zhi-Gang Cai
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

10.  Contemporary Management of Benign and Malignant Parotid Tumors.

Authors:  Jovanna Thielker; Maria Grosheva; Stephan Ihrler; Andrea Wittig; Orlando Guntinas-Lichius
Journal:  Front Surg       Date:  2018-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.